About Torigen Pharmaceuticals
Torigen is a private equity funded company delivering accessible and affordable companion animal immuno-oncology products for pets. Our initial patented product line utilizes a small portion of an animal’s tumor to create a personalized cancer vaccine. With over 10 years of supporting pre-clinical research, Torigen is committed to developing innovative veterinary cancer treatments.
More information on this position will be added shortly.